MedTrace Logo

CGA-TAVI Registry to Evaluate the Predictive Value of a CGA in Predicting TAVI Outcomes

NCT01991444 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2017-04-05

No results posted yet for this study

Summary

Registry study to evaluate the predictive value of a comprehensive geriatric assessment with regard to the outcome of a transcatheter aortic valve Implantation.

It will be evaluated which parts of the comprehensive geriatric assessment (CGA) are best suited to predict the therapeutic success of a heart valve Implantation in elderly ( \> 80 years) Patient. Possible participants are all Patient of 80 years or above for whom the implantation of a Edwards Sapien XT aortic valve is planned

Conditions

  • Aortic Valve Stenosis

Interventions

OTHER

TAVI

no Intervention planned, Observation only

Sponsors & Collaborators

  • Institut für Pharmakologie und Präventive Medizin

    lead NETWORK

Principal Investigators

  • Andrea Ungar, MD · Geriatric Cardiology and Medicine - U. of Florence

Eligibility

Min Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-12-31
Completion
2017-02-28

Countries

  • Canada
  • Italy
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01991444 on ClinicalTrials.gov